Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
White Label Liquid, Inc. is a contract manufacturing organization (CMO) specializing in the production of custom-blended hemp-derived CBD products and e-liquids. Based in Daytona Beach, Florida, the company operates a 51,000-square-foot facility where it provides end-to-end services including product formulation, branding, design, and customized packaging. Its product portfolio encompasses a wide range of consumer health and wellness items such as CBD oils, gummies, terpenes, lotions, and pre-filled vape pens. White Label Liquid serves a global clientele of brands, distributors, and retailers, offering a production capacity of approximately 50,000 units per day. The company is publicly traded on the OTC Pink Sheets under the ticker symbol WLAB and positions itself as a one-stop shop for businesses looking to enter or expand within the cannabinoid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on White Label Liquid.